Lisa A. Thompson, PharmD, BCOP

What actions are being taken in regard to current shortages of chemotherapeutic agents?

Should patients receive a test dose of bleomycin? If yes, should the test dose be administered with every dose or just the initial dose?

How can chemo brain be managed?

What data are there to support the use of noni in oncology patients? Can it be incorporated safely with chemotherapy?

Who should receive a test dose prior to a full-dose iron infusion?

What should nurses be aware of when administering denosumab? What are the best strategies for managing vaginal dryness caused by hormonal therapy for breast cancer?

What role does medication play in managing fatigue? Can neuropathy from oxaliplatin therapy be effectively treated or prevented?

This month’s questions: Giving Neulasta on the day of chemotherapy and strategies for managing opioid induced constipation.

Studies show that alternate dosages of fulvestrant may be efficacious, and adverse effects are similar in all regimens.

This month’s questions: retreating with rituximab after an allergic reaction and administering the new prostate cancer immunotherapy.